Ftse Mib
34.817,06
0,46%
DAX
18.742,22
-0,08%
S&P 500
5.221,42
-0,02%
NASDAQ
16.381,23
0,25%
Bitcoin
63.084,77
2,66%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Evgen Pharma Plc (EVG) Evgen Pharma Plc (EVG) Notizie

EVG

Evgen Pharma (EVG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG
DataOraFonteTitoloSimboloCompagnia
25/04/202421:57Alliance NewsAlliance NewsTRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading wellLSE:EVGEvgen Pharma Plc
25/04/202416:46RNS Regulatory NewsEvgen Pharma PLC Change of NameLSE:EVGEvgen Pharma Plc
22/04/202411:11RNS Regulatory NewsEvgen Pharma PLC Holding(s) in CompanyLSE:EVGEvgen Pharma Plc
05/04/202416:39RNS Regulatory NewsEvgen Pharma PLC Director/PDMR ShareholdingLSE:EVGEvgen Pharma Plc
04/04/202418:24Alliance NewsAlliance NewsTRADING UPDATES: Northcoders launches bootcamp; Schroder investsLSE:EVGEvgen Pharma Plc
04/04/202414:59RNS Regulatory NewsEvgen Pharma PLC Result of General MeetingLSE:EVGEvgen Pharma Plc
04/04/202408:00RNS Regulatory NewsEvgen Pharma PLC Result of Retail OfferLSE:EVGEvgen Pharma Plc
19/03/202420:47Alliance NewsAlliance NewsEARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flatLSE:EVGEvgen Pharma Plc
19/03/202418:03RNS Regulatory NewsEvgen Pharma PLC Retail OfferLSE:EVGEvgen Pharma Plc
19/03/202418:00RNS Regulatory NewsEvgen Pharma PLC Acquisition, Fundraising and Change of NameLSE:EVGEvgen Pharma Plc
27/02/202416:59Alliance NewsAlliance NewsEvgen Pharma finds evidence of SFX-01 activity in colon cancer modelsLSE:EVGEvgen Pharma Plc
27/02/202408:00RNS Non-RegulatoryEvgen Pharma PLC SFX-01 positive update in bowel cancer modelsLSE:EVGEvgen Pharma Plc
19/02/202412:45Alliance NewsAlliance NewsEvgen Pharma shares up on studies into SFX-01 product progressing wellLSE:EVGEvgen Pharma Plc
19/02/202412:22RNS Non-RegulatoryEvgen Pharma PLC Positive update on SFX-01 in vitro GBM studiesLSE:EVGEvgen Pharma Plc
09/02/202419:53Alliance NewsAlliance NewsTRADING UPDATES: Apax opts against lifting offer; DCI enters loan dealLSE:EVGEvgen Pharma Plc
09/02/202412:01RNS Regulatory NewsEvgen Pharma PLC Notice of Dispute lodged with Stalicla SALSE:EVGEvgen Pharma Plc
16/01/202419:59Alliance NewsAlliance NewsIN BRIEF: Evgen partner raises USD17.4 million to support pipelineLSE:EVGEvgen Pharma Plc
16/01/202416:07RNS Non-RegulatoryEvgen Pharma PLC Series B Fund Raise by partner, Stalicla SALSE:EVGEvgen Pharma Plc
22/12/202319:06Alliance NewsAlliance NewsIN BRIEF: Evgen appoints Toni Hanninen as permanent CFOLSE:EVGEvgen Pharma Plc
22/12/202308:00UK RegulatoryEvgen Pharma PLC Directorate ChangesLSE:EVGEvgen Pharma Plc
13/11/202308:00RNS Non-RegulatoryEvgen Pharma PLC Upcoming conferencesLSE:EVGEvgen Pharma Plc
31/10/202315:38Alliance NewsAlliance NewsTRADING UPDATES: Acuity RM wins contract; Georgia Capital ups earningsLSE:EVGEvgen Pharma Plc
31/10/202308:00UK RegulatoryEvgen Pharma PLC Half-year ReportLSE:EVGEvgen Pharma Plc
26/10/202308:00RNS Non-RegulatoryEvgen Pharma PLC Erasmus Medical Center begins glioblastoma studiesLSE:EVGEvgen Pharma Plc
19/10/202320:39Alliance NewsAlliance NewsIN BRIEF: Evgen showcases importance of new enteric-coated formulationLSE:EVGEvgen Pharma Plc
19/10/202315:26RNS Non-RegulatoryEvgen Pharma PLC Authored Article PublicationLSE:EVGEvgen Pharma Plc
05/09/202315:22Alliance NewsAlliance NewsEvgen Pharma hires interim CFO from Faron, chair to retire this monthLSE:EVGEvgen Pharma Plc
15/08/202311:01Alliance NewsAlliance NewsEvgen Pharma says trial shows new SFX-01 drug formulation is safeLSE:EVGEvgen Pharma Plc
15/08/202308:00UK RegulatoryEvgen Pharma PLC Final Report from Phase 1b PK/PD studyLSE:EVGEvgen Pharma Plc
03/08/202313:38UK RegulatoryEvgen Pharma PLC Rule 17 DisclosureLSE:EVGEvgen Pharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG

La tua Cronologia

EU
BIRAC
Bird AM Bird 9% Due 11/3...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network